Skip to main content

State VISA Inspection Overlap & Jurisdiction

BR-unique

Brazil's three-tier health surveillance system means that medical device companies may be subject to inspection by ANVISA (federal), the state VISA body, and the municipal VISA body — all with overlapping but distinct jurisdiction. This is a uniquely complex enforcement environment with no direct parallel in EU, US, AU, SG, or CA.

Jurisdictional division

LevelJurisdictionKey inspection activities
ANVISA (federal)NationalGMP inspections; CBPF issuance; market surveillance
State VISA (e.g., CVISA-SP, VISA-RJ)State territoryLocal GMP inspections; AFE endorsement; market surveillance within the state
Municipal VISAMunicipal territoryLicença de Funcionamento inspections; local distribution and retail

What happens when multiple bodies inspect the same company?

A company may receive inspection visits from ANVISA and the state VISA independently. State VISA inspections generally apply the same GMP standards as ANVISA inspections (both reference RDC 752/2022). However:

  • State VISA inspectors may have different interpretations of some requirements;
  • A state VISA finding can trigger ANVISA involvement (and vice versa);
  • In some states, a state VISA-issued CBPF may be accepted by ANVISA for Class I devices; however, ANVISA inspection and issuance of a federal CBPF is typically required for Class II, III, or IV devices regardless of state VISA involvement.

Practical advice

  • Establish a good relationship with the state VISA body in your state as well as ANVISA federally.

  • Treat state VISA inspections with the same seriousness as ANVISA inspections.

  • Ensure the Responsável Técnico is familiar with both ANVISA and state VISA requirements.

  • ANVISA — SNVS State Contacts


Official sources

Verify all information against official ANVISA sources before making regulatory decisions.

"Although both ANVISA and state VISA apply the same GMP standards, ANVISA holds final authority over national registration decisions. If a state VISA inspection uncovers serious GMP deficiencies, ANVISA may initiate a federal inspection and take precedence in enforcement actions such as facility closure or registration cancellation."